Gene · 1871
Papers3,808
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
461 to 480 of 3,808
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Centrosome Defects in Hematological Malignancies: Molecular Mechanisms and Therapeutic Insights. | Blood Sci | 2022 | 36518599 | PubTator, text mining | PubMed |
| Discovery of synthetic lethal interactions from large-scale pan-cancer perturbation screens. | Nat Commun | 2022 | 36517508 | PubTator, text mining | PubMed |
| The importance of fusion protein activity in Ewing sarcoma and the cell intrinsic and extrinsic factors that regulate it: A review. | Front Oncol | 2022 | 36505823 | PubTator, text mining | PubMed |
| Biomarkers of Response and Resistance to CDK4/6 Inhibitors in Breast Cancer: Hints from Liquid Biopsy and microRNA Exploration. | Int J Mol Sci | 2022 | 36498861 | PubTator, text mining | PubMed |
| Ethnic and racial-specific differences in levels of centrosome-associated mitotic kinases, proliferative and epithelial-to-mesenchymal markers in breast cancers. | Cell Div | 2022 | 36494865 | PubTator, text mining | PubMed |
| New roles for AP-1/JUNB in cell cycle control and tumorigenic cell invasion via regulation of cyclin E1 and TGF-β2. | Genome Biol | 2022 | 36494864 | PubTator, text mining | PubMed |
| Genomic profiling and network-level understanding uncover the potential genes and the pathways in hepatocellular carcinoma. | Front Genet | 2022 | 36479247 | PubTator, text mining | PubMed |
| Identification and validation of an E2F-related gene signature for predicting recurrence-free survival in human prostate cancer. | Cancer Cell Int | 2022 | 36471446 | PubTator, text mining | PubMed |
| Roles of circular RNAs in the pathogenesis and treatment of pancreatic cancer. | Front Cell Dev Biol | 2022 | 36467402 | PubTator, text mining | PubMed |
| Prediction of type 2 diabetes using genome-wide polygenic risk score and metabolic profiles: A machine learning analysis of population-based 10-year prospective cohort study. | EBioMedicine | 2022 | 36462406 | PubTator, text mining | PubMed |
| Knockdown of Brachyury Suppresses Breast Cancer Cell Proliferation and Migration via Targeting E2F3. | J Oncol | 2022 | 36457717 | PubTator, text mining | PubMed |
| Role of microRNA-34b-5p in cancer and injury: how does it work? | Cancer Cell Int | 2022 | 36457043 | PubTator, text mining | PubMed |
| The role of long noncoding RNAs in therapeutic resistance in cervical cancer. | Front Cell Dev Biol | 2022 | 36438563 | PubTator, text mining | PubMed |
| A Concise Review on Dysregulation of LINC00665 in Cancers. | Cells | 2022 | 36429005 | PubTator, text mining | PubMed |
| Tiliroside suppresses triple-negative breast cancer as a multifunctional CAXII inhibitor. | Cancer Cell Int | 2022 | 36424626 | PubTator, text mining | PubMed |
| Retinoblastoma: Review and new insights. | Front Oncol | 2022 | 36408154 | PubTator, text mining | PubMed |
| Profiling mRNA, miRNA and lncRNA expression changes in endothelial cells in response to increasing doses of ionizing radiation. | Sci Rep | 2022 | 36402833 | PubTator, text mining | PubMed |
| Prognostic potential of miR-144 in various cancers: A meta-analysis. | Medicine (Baltimore) | 2022 | 36401491 | PubTator, text mining | PubMed |
| A bioinformatics analysis for diagnostic roles of the E2F family in esophageal cancer. | J Gastrointest Oncol | 2022 | 36388667 | PubTator, text mining | PubMed |
| HOXA-AS2 may predict the prognosis of solid tumors among Chinese patients: A meta-analysis and bioinformatic analysis. | Front Oncol | 2022 | 36387249 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1871/papers?page=24